Stay updated on Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    0.7%
    Check dated 2025-07-04T04:15:37.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.5%
    Check dated 2025-06-19T20:06:17.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T11:25:09.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.9%
    Check dated 2025-05-29T06:16:35.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T18:55:58.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed information about cutaneous squamous cell carcinoma (cSCC) and the addition of new collaborators and a revision note. The core content related to cSCC treatment and prognosis has been largely deleted, which may impact the comprehensiveness of the information provided.
    Difference
    62%
    Check dated 2025-04-16T13:23:23.000Z thumbnail image

Stay in the know with updates to Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.